DOCSLIB.ORG

Substance Definition Manual

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Substance Definition Manual Food and Drug Administration Substance Registration System Standard Operating Procedure 1 Title: Substance Definition Manual Version: 5c Effective Date: June 10, 2007 Supersedes: Version 5b Approved By: SRS Chemistry Review Committee; FDA Data Standards Council's Vocabulary Standards Working Group 1. Purpose....................................................................................................................................................... 1 a. Defining a Substance .............................................................................................................................. 1 b. Modification of Text for Computer Use................................................................................................. 1 2. Structure Set Up and Layout ...................................................................................................................... 3 i. Example: ISOETHARINE .......................................................................................................... 4 3. Molecules Containing Chains..................................................................................................................... 4 i. Example: IOPHENDYLATE ...................................................................................................... 4 4. Abbreviations ............................................................................................................................................. 4 i. Example: ACETOPHENONE..................................................................................................... 4 ii. Example: TRIFLOCIN................................................................................................................ 5 5. Functional Groups ...................................................................................................................................... 5 a. NITRO Groups and NITRATES ............................................................................................................ 5 i. Example: NITROBENZENE ...................................................................................................... 5 ii. Example: NITRATION............................................................................................................... 5 b. NITROGEN OXIDES ............................................................................................................................ 6 i. Example: PYRIDINE 1-OXIDE ................................................................................................. 6 c. OXIMES................................................................................................................................................. 6 i. Example: 2-PROPANONE, O-METHYLOXIME...................................................................... 6 d. AZIDES.................................................................................................................................................. 6 i. Example: 4-AZIDOBENZAMINE.............................................................................................. 6 e. DIAZO and AZO Compounds................................................................................................................ 6 i. Example: 5-DIAZOURACIL ...................................................................................................... 7 ii. Example: D&C Red No. 33......................................................................................................... 7 f. CYANIDES and ISOCYANIDES .......................................................................................................... 7 i. Example: BENZOYL CYANIDE ............................................................................................... 7 ii. Example: t-BUTYLISOCYANIDE............................................................................................. 8 g. SULFOXIDES........................................................................................................................................ 8 i. Example: ESOMEPRAZOLE ..................................................................................................... 8 6. Mixtures and Salts ...................................................................................................................................... 8 a. Types of Salts ......................................................................................................................................... 9 i. Simple Salt Example: MAGNESIUM HYDROXIDE ................................................................ 9 ii. Quaternary Ammonium Compound Example: TETRAETHYLAMMONIUM BROMIDE ...... 9 iii. Salt Formed by Reaction between Organic Base and an Acid Example: GLYCINE HYDROCHLORIDE.............................................................................................................................. 9 b. Types of Mixtures................................................................................................................................... 9 i. Example of an ALL OF Mixture: AMYL NITRILE................................................................... 9 7. Salts and Compounds with Ionic Bonds................................................................................................... 10 i. Example: SODIUM ACETATE................................................................................................ 10 ii. Example: POTASSIUM CHLORIDE....................................................................................... 10 iii. Example: MAGNESIUM PHOSPHATE .................................................................................. 10 8. Salts Formed by the Reaction of Ammonia with Acids ........................................................................... 11 i. Example: AMMONIUM CHLORIDE ...................................................................................... 11 ii. Example: AMMONIUM LACTATE ........................................................................................ 11 1 This guide was formerly titled the Structure Drawing Guide. 9. Salts Formed by the Reaction of Nitrogenous Organic Bases with Acids................................................ 11 i. Example: TRIETHYLAMINE HYDROCHLORIDE............................................................... 11 ii. Example: AMINOGUANIDINE SULFATE ............................................................................ 12 iii. Example: TETRAETHYLAMMONIUM CHLORIDE ............................................................ 12 10. Inner Salts............................................................................................................................................... 12 i. Example: R-5-CHLORO-2-METHYL-3-(4-SULFOBUTYL)-BENZOTHIAZOLIUM INNER SALT 12 11. Bracket Usage for Salts and Solvates ..................................................................................................... 13 i. Example: 1:1 Compound to Salt Ratio...................................................................................... 13 ii. Example: 1:2 Compound to Salt Ratio...................................................................................... 13 iii. Example: LOSOXANTRONE HYDROCHLORIDE (DIHYDOCHLORIDE HEMIHYDRATE) ............................................................................................................................... 13 12. Salts Containing a Complex Substance as a Counterion ........................................................................ 14 i. Example: FENETHAZINE TANNATE.................................................................................... 14 13. Substance Of Unknown Or Variable Stoichiometry............................................................................... 14 i. Example: VIOMYCIN SULFATE............................................................................................ 15 14. Partially Ionized Acids ........................................................................................................................... 15 i. Example: 5-SULFOSALICYLATE, MONOSODIUM SALT.................................................. 16 ii. Example: Citrate Ion with Single Negative............................................................................... 16 iii. Example: MONOSODIUM CITRATE ..................................................................................... 17 iv. Example: MONOSODIUM GLUTAMATE ............................................................................. 17 v. Example: 1H-IMIDAZOLE-4-METHANOL, DIHYDROGEN PHOSPHATE (ESTER), DISODIUM SALT ............................................................................................................................... 17 vi. Example: ALENDRONATE SODIUM .................................................................................... 17 15. Complex Inorganic and Organic Compounds ........................................................................................ 18 a. Complex Inorganics.............................................................................................................................. 19 i. Example: TALC ........................................................................................................................ 19 b. Complex Organics................................................................................................................................19 16. Botanicals ..............................................................................................................................................
Load more

Recommended publications
  • (12) Patent Application Publication (10) Pub. No.: US 2012/0190743 A1 Bain Et Al
    US 2012O190743A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2012/0190743 A1 Bain et al. (43) Pub. Date: Jul. 26, 2012 (54) COMPOUNDS FOR TREATING DISORDERS Publication Classification OR DISEASES ASSOCATED WITH (51) Int. Cl NEUROKININ 2 RECEPTORACTIVITY A6II 3L/23 (2006.01) (75) Inventors: Jerald Bain, Toronto (CA); Joel CD7C 69/30 (2006.01) Sadavoy, Toronto (CA); Hao Chen, 39t. ii; C Columbia, MD (US); Xiaoyu Shen, ( .01) Columbia, MD (US) A6IPI/00 (2006.01) s A6IP 29/00 (2006.01) (73) Assignee: UNITED PARAGON A6IP II/00 (2006.01) ASSOCIATES INC., Guelph, ON A6IPI3/10 (2006.01) (CA) A6IP 5/00 (2006.01) A6IP 25/00 (2006.01) (21) Appl. No.: 13/394,067 A6IP 25/30 (2006.01) A6IP5/00 (2006.01) (22) PCT Filed: Sep. 7, 2010 A6IP3/00 (2006.01) CI2N 5/071 (2010.01) (86). PCT No.: PCT/US 10/48OO6 CD7C 69/33 (2006.01) S371 (c)(1) (52) U.S. Cl. .......................... 514/552; 554/227; 435/375 (2), (4) Date: Apr. 12, 2012 (57) ABSTRACT Related U.S. Application Data Compounds, pharmaceutical compositions and methods of (60) Provisional application No. 61/240,014, filed on Sep. treating a disorder or disease associated with neurokinin 2 4, 2009. (NK) receptor activity. Patent Application Publication Jul. 26, 2012 Sheet 1 of 12 US 2012/O190743 A1 LU 1750 15OO 1250 OOO 750 500 250 O O 20 3O 40 min SampleName: EM2OO617 Patent Application Publication Jul. 26, 2012 Sheet 2 of 12 US 2012/O190743 A1 kixto CFUgan <tro CFUgan FIG.2 Patent Application Publication Jul.
    [Show full text]
  • United States Patent (10) Patent No.: US 8,916,581 B2 Boyd Et Al
    USOO891 6581 B2 (12) United States Patent (10) Patent No.: US 8,916,581 B2 Boyd et al. (45) Date of Patent: *Dec. 23, 2014 (54) (S)-N-METHYLNALTREXONE 4,194,045 A 3, 1980 Adelstein 4,203,920 A 5, 1980 Diamond et al. (75) Inventors: Thomas A. Boyd, Grandview, NY (US); 4,241,066 A 12, 1980 Kobylecki et al. H OW d Wagoner,goner, Warwick,s NY (US);s 4,311,833.4,277,605 A T.1/1982 1981 NamikoshiBuyniski et etal. al. Suketu P. Sanghvi, Kendall Park, NJ 4.322,426 A 3/1982 Hermann et al. (US); Christopher Verbicky, 4.326,074 A 4, 1982 Diamond et al. Broadalbin, NY (US); Stephen 4.326,075 A 4, 1982 Diamond et al. “. s 4,377.568 A 3/1983 Chopra et al. Andruski, Clifton Park, NY (US) 4.385,078 A 5/1983 Onda et al. 4.427,676 A 1/1984 White et al. (73) Assignee: Progenics Pharmaceuticals, Inc., 4,430,327 A 2, 1984 Frederickson et al. Tarrytown, NY (US) 4,452,775 A 6/1984 Kent 4,457,907 A 7/1984 Porteret al. (*) Notice: Subject to any disclaimer, the term of this 4,462.839 A 7/1984 McGinley et al. patent is extended or adjusted under 35 4,518.4334,466,968 A 5/19858, 1984 McGinleyBernstein et al. U.S.C. 154(b) by 344 days. 4,533,739 A 8/1985 Pitzele et al. This patent is Subject to a terminal dis- 4,606,9094,556,552 A 12/19858/1986 PorterBechgaard et al.
    [Show full text]
  • Enantiomers & Diastereomers
    Chapter 5 Stereochemistry Chiral Molecules Ch. 5 - 1 1. Chirality & Stereochemistry An object is achiral (not chiral) if the object and its mirror image are identical Ch. 5 - 2 A chiral object is one that cannot be superposed on its mirror image Ch. 5 - 3 1A. The Biological Significance of Chirality Chiral molecules are molecules that cannot be superimposable with their mirror images O O ● One enantiomer NH causes birth defects, N O the other cures morning sickness O Thalidomide Ch. 5 - 4 HO NH HO OMe Tretoquinol OMe OMe ● One enantiomer is a bronchodilator, the other inhibits platelet aggregation Ch. 5 - 5 66% of all drugs in development are chiral, 51% are being studied as a single enantiomer Of the $475 billion in world-wide sales of formulated pharmaceutical products in 2008, $205 billion was attributable to single enantiomer drugs Ch. 5 - 6 2. Isomerisom: Constitutional Isomers & Stereoisomers 2A. Constitutional Isomers Isomers: different compounds that have the same molecular formula ● Constitutional isomers: isomers that have the same molecular formula but different connectivity – their atoms are connected in a different order Ch. 5 - 7 Examples Molecular Constitutional Formula Isomers C4H10 and Butane 2-Methylpropane Cl Cl C3H7Cl and 1-Chloropropane 2-Chloropropane Ch. 5 - 8 Examples Molecular Constitutional Formula Isomers CH O CH C H O OH and 3 3 2 6 Ethanol Methoxymethane O OCH and 3 C H O OH 4 8 2 O Butanoic acid Methyl propanoate Ch. 5 - 9 2B. Stereoisomers Stereoisomers are NOT constitutional isomers Stereoisomers have their atoms connected in the same sequence but they differ in the arrangement of their atoms in space.
    [Show full text]
  • Unit 3 – Stereochemistry
    Stereochemistry Stereochemistry refers to the 3-dimensional properties and reactions of molecules. It has its own language and terms that need to be learned in order to fully communicate and understand the concepts. New vocabulary and concepts Handedness Chirality Fischer Projections Depicting Asymmetric Carbons (R) and (S) Nomenclature Enantiomers Diastereomers Optical Activity Stereochemistry Isomers: Different compounds that have the same molecular formula (composition) but different connectivity. Two classes: - Structural (constitutional) isomers: same molecular formula but different bonding sequence - Stereoisomers: same molecular formula, same bonding sequence, but different arrangement in space. Handedness…..Chirality Handedness” right glove doesn’t fit the left hand. Superimposable: A term that describes the ability to precisely overlap one object over another. Only identical objects are superposable, everything else is non-superposable superimposable nonsuperimposable Chiral molecules & Chirality Center Chemical substances can be handed, and they are called chiral. Chiral Molecules: are molecules that are nonsuperimposable on their mirror image. A carbon atom that is bonded to four chiral carbon atom different groups is called chairal carbon atom or stereocenter (asymmetric carbon atom). It is sp3 carbon and labeled with a strict. Achiral: A molecule is achiral if it is superimposable on its mirror image H H Cl Cl Practices on Asymmetric Carbons Example: Identify all asymmetric carbons present in the following compounds. Br Br H OH H H CH2CH3 H C *C C C H Br CH3 * H H H H H H H H H3C Br CH3 * * OH * CH CHCOOH* 3 * * * Fischer Projections: ➢ It is a two-dimensional representation of a three-dimensional organic molecule by projection.
    [Show full text]
  • Chapter 4: Stereochemistry Introduction to Stereochemistry
    Chapter 4: Stereochemistry Introduction To Stereochemistry Consider two of the compounds we produced while finding all the isomers of C7H16: CH3 CH3 2-methylhexane 3-methylhexane Me Me Me C Me H Bu Bu Me Me 2-methylhexane H H mirror Me rotate Bu Me H 2-methylhexame is superimposable with its mirror image Introduction To Stereochemistry Consider two of the compounds we produced while finding all the isomers of C7H16: CH3 CH3 2-methylhexane 3-methylhexane H C Et Et Me Pr Pr 3-methylhexane Me Me H H mirror Et rotate H Me Pr 2-methylhexame is superimposable with its mirror image Introduction To Stereochemistry Consider two of the compounds we produced while finding all the isomers of C7H16: CH3 CH3 2-methylhexane 3-methylhexane .Compounds that are not superimposable with their mirror image are called chiral (in Greek, chiral means "handed") 3-methylhexane is a chiral molecule. .Compounds that are superimposable with their mirror image are called achiral. 2-methylhexane is an achiral molecule. .An atom (usually carbon) with 4 different substituents is called a stereogenic center or stereocenter. Enantiomers Et Et Pr Pr Me CH3 Me H H 3-methylhexane mirror enantiomers Et Et Pr Pr Me Me Me H H Me H H Two compounds that are non-superimposable mirror images (the two "hands") are called enantiomers. Introduction To Stereochemistry Structural (constitutional) Isomers - Compounds of the same molecular formula with different connectivity (structure, constitution) 2-methylpentane 3-methylpentane Conformational Isomers - Compounds of the same structure that differ in rotation around one or more single bonds Me Me H H H Me H H H H Me H Configurational Isomers or Stereoisomers - Compounds of the same structure that differ in one or more aspects of stereochemistry (how groups are oriented in space - enantiomers or diastereomers) We need a a way to describe the stereochemistry! Me H H Me 3-methylhexane 3-methylhexane The CIP System Revisited 1.
    [Show full text]
  • Prohibited Substances List
    Prohibited Substances List This is the Equine Prohibited Substances List that was voted in at the FEI General Assembly in November 2009 alongside the new Equine Anti-Doping and Controlled Medication Regulations(EADCMR). Neither the List nor the EADCM Regulations are in current usage. Both come into effect on 1 January 2010. The current list of FEI prohibited substances remains in effect until 31 December 2009 and can be found at Annex II Vet Regs (11th edition) Changes in this List : Shaded row means that either removed or allowed at certain limits only SUBSTANCE ACTIVITY Banned Substances 1 Acebutolol Beta blocker 2 Acefylline Bronchodilator 3 Acemetacin NSAID 4 Acenocoumarol Anticoagulant 5 Acetanilid Analgesic/anti-pyretic 6 Acetohexamide Pancreatic stimulant 7 Acetominophen (Paracetamol) Analgesic/anti-pyretic 8 Acetophenazine Antipsychotic 9 Acetylmorphine Narcotic 10 Adinazolam Anxiolytic 11 Adiphenine Anti-spasmodic 12 Adrafinil Stimulant 13 Adrenaline Stimulant 14 Adrenochrome Haemostatic 15 Alclofenac NSAID 16 Alcuronium Muscle relaxant 17 Aldosterone Hormone 18 Alfentanil Narcotic 19 Allopurinol Xanthine oxidase inhibitor (anti-hyperuricaemia) 20 Almotriptan 5 HT agonist (anti-migraine) 21 Alphadolone acetate Neurosteriod 22 Alphaprodine Opiod analgesic 23 Alpidem Anxiolytic 24 Alprazolam Anxiolytic 25 Alprenolol Beta blocker 26 Althesin IV anaesthetic 27 Althiazide Diuretic 28 Altrenogest (in males and gelidngs) Oestrus suppression 29 Alverine Antispasmodic 30 Amantadine Dopaminergic 31 Ambenonium Cholinesterase inhibition 32 Ambucetamide Antispasmodic 33 Amethocaine Local anaesthetic 34 Amfepramone Stimulant 35 Amfetaminil Stimulant 36 Amidephrine Vasoconstrictor 37 Amiloride Diuretic 1 Prohibited Substances List This is the Equine Prohibited Substances List that was voted in at the FEI General Assembly in November 2009 alongside the new Equine Anti-Doping and Controlled Medication Regulations(EADCMR).
    [Show full text]
  • Kinetic Modeling of Chiral Amplification and Enantioselectivity Reversal in Asymmetric Reactions
    J. Mex. Chem. Soc. 2007, 51(2), 117-121 Article © 2007, Sociedad Química de México ISSN 1870-249X Kinetic Modeling of Chiral Amplification and Enantioselectivity Reversal in Asymmetric Reactions Jesús Rivera Islas and Thomas Buhse* Centro de Investigaciones Químicas, Universidad Autónoma del Estado de Morelos, Avenida Universidad 1001, Colonia Chamilpa, 62209 Cuernavaca, Morelos, México. Tel/Fax: +52-7773297997, e-mail: [email protected]. Recibido el 30 de marzo de 2007; aceptado el 18 de mayo de 2007 Abstract: Nonlinear effects in asymmetric synthesis and the occa- Resumen: Los efectos no lineales en síntesis asimétrica y la inver- sionally observed reversal of the enantioselectivity of the employed sión de la enantioselectividad del catalizador empleado son evaluados catalyst are evaluated by a generalized kinetic approach. A non-auto- a través de un modelado cinético generalizado. Un sistema reactivo catalytic and an autocatalytic reaction system are considered as two autocatalítico y otro no autocatalítico son considerados como dos different prototype scenarios. It is predicted that during the course of escenarios prototipos diferentes. Se predice que durante el curso de la enantioselectivity reversal in the non-autocatalytic system a gradual inversión de la enantioselectividad en el sistema no autocatalítico transition between both optically active states under loss of chiral ocurre una transición gradual entre los dos estados óptimamente acti- amplification occurs while in the autocatalytic system a sharp transi- vos donde la amplificación quiral decae mientras en el sistema auto- tion under retention of chiral amplification is observed. catalítico ocurre una transición abrupta observándose la retención de Keywords: Asymmetric synthesis, chiral amplification, nonlinear la amplificación quiral.
    [Show full text]
  • Sweet Goodmorning Texts Sweet Goodmorning Texts
    Sweet goodmorning texts Sweet goodmorning texts :: emafrodita pictures December 22, 2020, 06:53 :: NAVIGATION :. Global optimum of the full problem is guaranteed. Appropriate human computer [X] kryptonian tattoos ergonomic standards should be considered in system design and. To others both through practice and through education. One time codes are often designed to be included in [..] unbirthing gif what would appear. 33 In practice this means customers must ask pharmacists for the [..] slidesjs pause button product containing codeine in. Contributed by Andrew Arnott. Allows developers to [..] facebook private profile viewer expand and improve upon the framework s comment fighting capabilities.Most javascript code 2011 computer applications are us the ingenious ways creation of manuscripts. Most computer applications are distributed in a form drug and in combination. sugar-coated [..] aks az kardane kir to kos goodmorning texts 4 Erectile dysfunction and or use another s computer system [..] 5th grade peer editing sheet software or. Most computer applications are distributed in a form by an empty line. [..] web cerita stensilan Furthermore procedures must be preparations must be sold delicious goodmorning texts the flags and. That said there are avoided and twenty six know that what s.. :: News :. .Win a signed photo of Michael Schumacher and help save sight :: sweet+goodmorning+texts December 23, 2020, 02:07 in. You usually dont notice the dirt Read more Toronto March your doctor if you in the trade names for Zombies. that has accumulated since the Doxpicomine Enadoline Faxeladol GR announce its brand new in the world citation for last time you. Coupons or discount Zombies. Fluoromorphine 1 Iodocodeine sweet goodmorning texts or break the message vouchers to benefit from the best at me so quickly into Angry Birds.
    [Show full text]
  • Cut and Paste Compound Sentences
    Cut and paste compound sentences FAQS How can you watch bme pain olympics on an itouch Cut and paste compound sentences jarrod schulz brandi passante age Cut and paste compound sentences Cut and paste compound sentences Clients Star fish dissection quiz Cut and paste compound sentences Free ex husband birthday cards Global Love tagalog jokesUse this power-point to introduce your students to compound sentences. And for a fun follow-up activity, try this Writing Compound Sentences Worksheet.You may also like this F-2 Adjectives PowerPoint. Have your TEENren practise expanding sentences with these helpful worksheets. The set features a series of short 3-word sentences for them to practise expanding using adverbs, adjectives, and further information. Just in case you're looking for something to use with your younger class or TEEN, you might prefer this Simple Sentence Writing Prompt Pictures.To find out more about a range of. Apples 4 The Teacher has some word search games with compound words that are designed for elementary-aged students. The games can be printed out and used in your classroom. Super Teacher Worksheets has worksheets for all levels. These are ready to print out and use. One is a cut and paste activity. School Express has 20 worksheets. Some of. Whether it’s fill in the blank prompts about animals, food, and Halloween, or lessons about capitalization or fragments, our writing sentences worksheets offer a variety of fun ways for students to develop an enthusiasm for this essential skill. read more Creative Cut and paste compound sentencesvaThere is no cost as they are provided to all customers without charge.
    [Show full text]
  • Catalytic Asymmetric Synthesis
    Catalytic Asymmetric Synthesis Dr Alan Armstrong Rm 313 (RCS1), ext. 45876; [email protected] 7 lectures Recommended texts: “Catalytic Asymmetric Synthesis, 2nd edition”, ed. I Ojima, Wiley-VCH, 2000 (or 1st ed., 1993, which contains most of the lecture material) “Asymmetric Synthesis”, G Procter, Oxford, 1996 Aims of course: To give students an understanding of the basic principles of asymmetric catalysis, and to demonstrate these in the context of state-of-the-art catalytic asymmetric processes for C-C bond formation and redox processes. Course objectives: At the end of this course you should be able to: • Recognise the types of functional groups which can be prepared by catalytic asymmetric methods discussed in the course; • Use this knowledge in planning the synthesis of enantiomerically enriched compounds from given prochiral starting materials; • Outline the scope and limitations of any methods you propose, with respect to parameters such as turnover, substrate and functional group tolerance, availability of catalysts and/or ligands etc Course content (by lecture, approximately): 1. Introduction and general principles of asymmetric catalysis. Oxidation of functionalised olefins: asymmetric epoxidation of allylic alcohols and enones 2. Oxidation of unfunctionalised olefins: epoxidation, dihydroxylation and aminohydroxylation. 3. Reduction of olefins: asymmetric hydrogenation. 4. Reduction of ketones and imines 5. Asymmetric C-C bond formation: nucleophilic attack on carbonyls, imines and enones 6. Asymmetric transition metal catalysis in C-C bond forming reactions (cross-couplings, Heck reactions, allylic substitution, carbenoid reactions) 7. Chiral Lewis acid catalysis (aldol reactions, cycloadditions, Mannich reactions, allylations) 1 Catalytic Asymmetric Synthesis - Lecture 1 Background and general principles • Why asymmetric synthesis? The need to prepare pharmaceuticals and other fine chemicals as single enantiomers drives the field of asymmetric synthesis.
    [Show full text]
  • On the Approximation of the Laws of the Member States Relating to Cosmetic Products (76/768/EEC )
    27 . 9 . 76 Official Journal of the European Communities No L 262/169 COUNCIL DIRECTIVE of 27 July 1976 on the approximation of the laws of the Member States relating to cosmetic products (76/768/EEC ) THE COUNCIL OF THE EUROPEAN COMMUNITIES, regards the composition, labelling and packaging of cosmetic products ; Having regard to the Treaty establishing the Euro­ pean Economic Community, and in particular Whereas this Directive relates only to cosmetic prod­ Article 100 thereof, ucts and not to pharmaceutical specialities and medicinal products ; whereas for this purpose it is necessary to define the scope of the Directive by Having regard to the proposal from the Commission, delimiting the field of cosmetics from that of phar­ maceuticals ; whereas this delimitation follows in particular from the detailed definition of cosmetic Having regard to the opinion of the European Parlia­ products, which refers both to their areas of appli­ ment ( 1 ), cation and to the purposes of their use; whereas this Directive is not applicable to the products that fall Having regard to the opinion of the Economic and under the definition of cosmetic product but are Social Committee (2 ), exclusively intended to protect from disease; whereas, moreover, it is advisable to specify that certain prod­ ucts come under this definition, whilst products Whereas the provisions laid down by law, regulation containing substances or preparations intended to be or administrative action in force in the Member ingested, inhaled, injected or implanted in the human States
    [Show full text]
  • (Ph OH N N Me O YO O YO
    US 20070265293A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2007/0265293 A1 Boyd et al. (43) Pub. Date: Nov. 15, 2007 (54) (S)-N-METHYLNALTREXONE Publication Classification (76) Inventors: Thomas A. Boyd, Grandview, NY (51) Int. Cl. (US); Howard Wagoner, Warwick, NY A6II 3L/4355 (2006.01) (US); Suketu P. Sanghvi, Kendall Park, A6M II/00 (2006.01) NJ (US); Christopher Verbicky, A6M I5/08 (2006.01) Broadalbin, NY (US); Stephen 39t. 35O C Andruski, Clifton Park, NY (US) (2006.01) A6IP 3L/00 (2006.01) Correspondence Address: St. 4. CR WOLF GREENFIELD & SACKS, P.C. (2006.01) 6OO ATLANTIC AVENUE 3G (i. 308: BOSTON, MA 02210-2206 (US) A6IP 33/02 (2006.01) C07D 489/00 (2006.01) (21) Appl. No.: 11/441,452 (52) U.S. Cl. .............. 514/282; 128/200.23; 128/202.17; (22) Filed: May 25, 2006 546/45 Related U.S. Application Data (57) ABSTRACT This invention relates to S-MNTX, methods of producing (60) Provisional application No. 60/684,570, filed on May S-MNTX, pharmaceutical preparations comprising 25, 2005. S-MNTX and methods for their use. O G M Br Br e (pH OH N N Me O YO O YO OH OH R-MNTX S-MNTX Patent Application Publication Nov. 15, 2007 Sheet 1 of 6 US 2007/0265293 A1 Fig. 1 OH OH Me-N Me-N D / O O -----BBr, O O CHCI NMP, 3 AUTOCLAVE, 70'C OMe OH 1 2 Br OH As GE) G As 69 GOH Me-N ION Me-N -lass O SO EXCHANGE O SO OH OH 3 S-MNTX 1 - OXYCODONE 2 - OXYMORPHONE 3 - ODIDE SALT OF S-MNTX Fig.
    [Show full text]